Abstract
In this issue of Blood, Wang et al report on the response of splenic-derived hematopoietic stem and progenitor cells from patients with myelofibrosis (MF) to the Janus kinase (JAK) inhibitor, AZD1480.
MeSH terms
-
Female
-
Humans
-
Janus Kinase 2 / antagonists & inhibitors*
-
Male
-
Primary Myelofibrosis / drug therapy*
-
Pyrazoles / pharmacology*
-
Pyrimidines / pharmacology*
-
Spleen / cytology*
-
Stem Cells / drug effects*
Substances
-
AZD 1480
-
Pyrazoles
-
Pyrimidines
-
JAK2 protein, human
-
Janus Kinase 2